Versant Capital Management, Inc Abbott Laboratories Transaction History

Versant Capital Management, Inc

$454 Million
Q4 2024

A detailed history of Versant Capital Management, Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Versant Capital Management, Inc holds 2,998 shares of ABT stock, worth $341,262. This represents 0.07% of its overall portfolio holdings.

Number of Shares

2,998

Previous 1,390 115.68%

Holding current value

$341,262

Previous $158,000 114.56%

% of portfolio

0.07%

Previous 0.04%

34 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 02, 2025	BUY	$111.93 - $119.39 $179,983 - $191,979	1,608 Added 115.68%	2,998 $339,000
Q3 2024 Oct 07, 2024	BUY	$100.07 - $118.13 $18,412 - $21,735	184 Added 15.26%	1,390 $158,000
Q2 2024 Jul 05, 2024	BUY	$100.73 - $112.44 $17,728 - $19,789	176 Added 17.09%	1,206 $125,000
Q1 2024 Apr 03, 2024	BUY	$109.52 - $120.96 $8,980 - $9,918	82 Added 8.65%	1,030 $117,000
Q4 2023 Jan 08, 2024	SELL	$90.19 - $110.4 $3,066 - $3,753	-34 Reduced 3.46%	948 $104,000
Q3 2023 Oct 11, 2023	BUY	$95.53 - $114.62 $5,827 - $6,991	61 Added 6.62%	982 $95,000
Q2 2023 Jul 10, 2023	BUY	$100.78 - $112.29 $8,767 - $9,769	87 Added 10.43%	921 $100,000
Q1 2023 Apr 10, 2023	SELL	$96.86 - $114.01 $1,356 - $1,596	-14 Reduced 1.65%	834 $84,000
Q3 2022 Dec 30, 2022	BUY	$96.76 - $112.03 $1,548 - $1,792	16 Added 1.92%	848 $82,000
Q2 2022 Aug 02, 2022	SELL	$102.07 - $123.37 $612 - $740	-6 Reduced 0.72%	832 $90,000
Q1 2022 Apr 29, 2022	SELL	$114.02 - $139.04 $570 - $695	-5 Reduced 0.59%	838 $99,000
Q4 2021 Jan 06, 2022	SELL	$115.53 - $141.46 $1,501 - $1,838	-13 Reduced 1.52%	843 $119,000
Q3 2021 Oct 29, 2021	SELL	$116.66 - $129.06 $1,399 - $1,548	-12 Reduced 1.38%	856 $101,000
Q2 2021 Jul 22, 2021	SELL	$105.79 - $124.53 $211 - $249	-2 Reduced 0.23%	868 $101,000
Q1 2021 Apr 27, 2021	BUY	$108.84 - $128.23 $4,788 - $5,642	44 Added 5.33%	870 $104,000
Q4 2020 Feb 08, 2021	SELL	$105.0 - $114.42 $189,000 - $205,956	-1,800 Reduced 68.55%	826 $90,000
Q3 2020 Nov 02, 2020	SELL	$91.64 - $111.29 $35,739 - $43,403	-390 Reduced 12.93%	2,626 $285,000
Q2 2020 Jul 16, 2020	BUY	$76.57 - $98.0 $31,240 - $39,984	408 Added 15.64%	3,016 $275,000
Q1 2020 Apr 17, 2020	BUY	$62.82 - $91.86 $3,832 - $5,603	61 Added 2.39%	2,608 $205,000
Q4 2019 Jan 28, 2020	SELL	$78.51 - $87.4 $942 - $1,048	-12 Reduced 0.47%	2,547 $221,000
Q3 2019 Oct 18, 2019	SELL	$81.84 - $88.74 $491 - $532	-6 Reduced 0.23%	2,559 $214,000
Q2 2019 Jul 16, 2019	SELL	$72.88 - $85.0 $17,126 - $19,975	-235 Reduced 8.39%	2,565 $215,000
Q1 2019 Apr 23, 2019	BUY	$66.22 - $80.06 $170,648 - $206,314	2,577 Added 1155.61%	2,800 $223,000
Q1 2019 Apr 23, 2019	SELL	$66.22 - $80.06 $171,509 - $207,355	-2,590 Reduced 92.07%	223 $223,000
Q1 2018 Apr 19, 2018	SELL	$56.27 - $63.62 $2,532 - $2,862	-45 Reduced 1.57%	2,813 $168,000
Q4 2017 Apr 19, 2018	BUY	$53.68 - $57.47 $11,755 - $12,585	219 Added 8.3%	2,858 $163,000
Q3 2017 Apr 23, 2018	SELL	$48.06 - $53.64 $3,316 - $3,701	-69 Reduced 2.55%	2,639 $140,000
Q2 2017 Apr 23, 2018	SELL	N/A	-79 Reduced 2.83%	2,708 $131,000
Q1 2017 Apr 23, 2018	BUY	N/A	201 Added 7.77%	2,787 $123,000
Q4 2016 Apr 23, 2018	SELL	N/A	-215 Reduced 7.68%	2,586 $99,000
Q3 2016 Apr 23, 2018	BUY	N/A	64 Added 2.34%	2,801 $118,000
Q2 2016 Apr 23, 2018	SELL	N/A	-48 Reduced 1.72%	2,737 $107,000
Q1 2016 Apr 23, 2018	SELL	N/A	-87 Reduced 3.03%	2,785 $116,000
Q4 2015 Apr 23, 2018	BUY	N/A	2,872	2,872 $128,000

Others Institutions Holding ABT

# of Institutions

3,187

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $199B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Versant Capital Management, Inc with notifications on news.

Account

Versant Capital Management, Inc Abbott Laboratories Transaction History